glp 1 review article GLP-1-based therapies for diabetes, obesity and beyond This article examines the potential

HR, 1.12

For high burden atherosclerosis, there was an observed attenuation of endothelial dysfunction in the liraglutide treatment group

Preclinical evidence supports the role of GLP-1RAs in alleviating neuropathic pain through the modulation of microglial activity, inflammatory cytokine production and -endorphin release [63, 65, 68, 70,71,72,73,74]

Reduced Body Fat Storage: Increasing insulin secretion and reducing glucagon secretion, helps prevent excessive glucose availability for energy, which may decrease body fat storage

It also has a longer half-life, meaning it stays active in the body for a longer period, which leads to more sustained appetite suppression and better blood sugar control